Mind Medicine (MindMed) Inc. has entered into an underwriting agreement for a public offering of approximately 9.3 million common shares at $7.00 each, aiming to raise about $70 million for research and development and general corporate purposes. As of June 30, 2024, the company reported preliminary cash and cash equivalents of approximately $243.1 million.